Metabolic Syndrome as a Risk for Coronary Heart Disease in Indonesia: A Longitudinal Study 2007-2014

Author:

Ramadhaniah, Fariha,Sudaryo Mondastri Korib,Syarif Syahrizal

Abstract

Introduction: Indonesia has a serious burden of cardiovascular disease, especially coronary heart disease (CHD). The prevalence of CHD has not in fact increased; however, there has been a significant increase in the prevalence of CHD risk factors. Several of these occurring together could cause metabolic syndrome, whose prevalence is relatively high in Indonesia, and consequently increase the risk of CHD. This study aims to obtain the risk of CHD in patients with metabolic syndrome in Indonesia. Methods: This is a retrospective cohort study with a median followed up of 6.8 years, secondary data from the Indonesian Family Life Survey (IFLS) waves 4 and 5 (2007-2014), and a study population of 6,571 respondents aged 40-69 years. The Joint Interim Statement criteria were used to define metabolic syndrome, with the omission of one component. Results: The prevalence of metabolic syndrome was 20%; the highest component was low HDL at 69.1%, followed by hypertension at 59.7%, and central obesity at 39.7%. The incidence of CHD was 2.72%, with an incidence rate 34per 100,000 person-years. Multivariate analysis found that the relative risk (RR) hazard ratio (HR) was 2.16 (95% CI 1.564-2.985). Conclusion: Subjects with metabolic syndrome had a two times higher risk of developing CHD, as adjusted by sex, age, smoking status, and physical activity.

Publisher

Universiti Putra Malaysia

Subject

General Medicine

Reference25 articles.

1. 1. Kementerian Kesehatan RI. Rencana Aksi Strategis Nasional Pencegahan dan Pengendalian Penyakit Tidak Menular (RAN PP-PTM) 2015-2019. Kementrian Kesehatan RI. 2017. p. 1–166.

2. 2. Badan Penelitian dan Pengembangan Kesehatan. Laporan_Nasional_RKD2018_FINAL.pdf [Internet]. Badan Penelitian dan Pengembangan Kesehatan. 2018. p. 198. Available from: http://labdata.litbang.kemkes.go.id/images/download/laporan/RKD/2018/Laporan_Nasional_RKD2018_FINAL.pdf

3. 3. Kusuma D, Kusumawardani N, Ahsan A, Sebayang SK, Amir V, Ng N. On the verge of a chronic disease epidemic: Comprehensive policies and actions are needed in Indonesia. Int Health. 2019;11(6):422–4. doi: 10.1093/inthealth/ihz025. doi: 10.1093/inthealth/ihz025.

4. 4. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International . Circulation. 2009;120(16):1640–5. doi: 10.1161/CIRCULATIONAHA.109.192644.

5. 5. Sigit FS, Tahapary DL, Trompet S, Sartono E, Willems Van Dijk K, Rosendaal FR, et al. The prevalence of metabolic syndrome and its association with body fat distribution in middle-aged individuals from Indonesia and the Netherlands: A cross-sectional analysis of two population-based studies. Diabetol Metab Syndr [Internet]. 2020;12(1):1–11. doi:10.1186/s13098-019-0503-1

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3